CCN Proteins and Breast Cancer

CCN 蛋白与乳腺癌

• 批准号: 7847271
• 负责人: Harold Phillip Koeffler
• 金额: $ 16.37万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-01 至 2012-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7847271
• 关键词: Advisory Committees; African American; Age; Ambulatory Care; Area; Arts; Binding; Biological; Breast; Breast Cancer Cell; Cancer Center; Cancer Patient; Cancer Research Project; Cancer cell line; Caucasians; Caucasoid Race; Characteristics; Chemopreventive Agent; Clinical; Clinical Pathology; Collaborations; Communication; Data; Development; Diagnosis; Disease; Dominant-Negative Mutation; Ethnic group; Faculty; Family; Future; Gene Proteins; Genome; Genomics; Goals; Growth; Growth Factor; Hematology; Hispanics; Historically Black Colleges and Universities; Immunohistochemistry; Integrins; Knowledge; Laboratories; Latina; Lead; Learning; Life; Malignant Neoplasms; Mammary Gland Parenchyma; Measures; Medical center; Medicine; Mentors; Methods; Minority; Molecular Diagnosis; Molecular Profiling; Monoclonal Antibodies; Mus; Names; National Cancer Institute; Neoplasm Metastasis; Outcome; Paraffin; Partner in relationship; Pathogenesis; Pathway interactions; Patients; Play; Population; Postdoctoral Fellow; Principal Investigator; Productivity; Prognostic Marker; Protein Binding; Protein Family; Proteins; RNA; Recruitment Activity; Research; Research Infrastructure; Research Methodology; Research Personnel; Research Training; Resistance; Role; Running; Sampling; Science; Scientist; Series; Services; Staining method; Stains; Students; Surgeon; Techniques; Technology; Testing; Therapeutic; Tissue Microarray; Training; Training Programs; Transgenic Animals; Transgenic Mice; Transgenic Organisms; Underserved Population; Universities; Validation; Woman; Work; Yin; anticancer research; chemotherapy; human FRAP1 protein; in vivo; insight; malignant breast neoplasm; medical schools; meetings; member; novel; novel therapeutic intervention; novel therapeutics; oncology; outcome forecast; overexpression; professor; prognostic; prognostic indicator; protein expression; receptor; response; skills; tumor progression